Firstly, our exploration of the mechanism behind NEURL3’s inhibition of NPC EMT and metastasis solely focused on the regulation of Vimentin by NEURL3, without delving into potential intermediate molecules. This evidence concerns the gene NEURL3 and nasopharyngeal carcinoma.